|Disease manifestations and pathogenic mechanisms of group A Streptococcus|
MJ Walker, TC Barnett, JD McArthur, JN Cole, CM Gillen, A Henningham, ...
Clinical microbiology reviews 27 (2), 264-301, 2014
|DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection|
MJ Walker, A Hollands, ML Sanderson-Smith, JN Cole, JK Kirk, ...
Nature medicine 13 (8), 981-985, 2007
|A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development|
M Sanderson-Smith, DMP De Oliveira, J Guglielmini, DJ McMillan, T Vu, ...
The Journal of infectious diseases 210 (8), 1325-1338, 2014
|Trigger for group A streptococcal M1T1 invasive disease|
JN Cole, JD McArthur, FC McKay, ML Sanderson-Smith, AJ Cork, ...
The FASEB journal 20 (10), 1745-1747, 2006
|Bacterial plasminogen receptors: mediators of a multifaceted relationship|
ML Sanderson-Smith, DMP De Oliveira, M Ranson, JD McArthur
Journal of Biomedicine and Biotechnology 2012, 2012
|Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection|
FC McKay, JD McArthur, ML Sanderson-Smith, S Gardam, BJ Currie, ...
Infection and immunity 72 (1), 364-370, 2004
|M protein‐mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate|
ML Sanderson-Smith, K Dinkla, JN Cole, AJ Cork, PG Maamary, ...
The FASEB Journal 22 (8), 2715-2722, 2008
|The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues|
ML Sanderson-Smith, M Dowton, M Ranson, MJ Walker
Journal of bacteriology 189 (4), 1435-1440, 2007
|Carbamazepine as a possible anthropogenic marker in water: occurrences, toxicological effects, regulations and removal by wastewater treatment technologies|
FI Hai, S Yang, MB Asif, V Sencadas, S Shawkat, M Sanderson-Smith, ...
Water 10 (2), 107, 2018
|Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation|
JD McArthur, FC McKay, V Ramachandran, P Shyam, AJ Cork, ...
The FASEB journal 22 (9), 3146-3153, 2008
|Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone|
PG Maamary, NLB Zakour, JN Cole, A Hollands, RK Aziz, TC Barnett, ...
The FASEB Journal 26 (11), 4675-4684, 2012
|The maintenance of high affinity plasminogen binding by group A streptococcal plasminogen-binding M-like protein is mediated by arginine and histidine residues within the a1 …|
ML Sanderson-Smith, MJ Walker, M Ranson
Journal of Biological Chemistry 281 (36), 25965-25971, 2006
|Divergence in the plasminogen-binding group a streptococcal M protein family: functional conservation of binding site and potential role for immune selection of variants|
M Sanderson-Smith, M Batzloff, KS Sriprakash, M Dowton, M Ranson, ...
Journal of Biological Chemistry 281 (6), 3217-3226, 2006
|Host responses to group a streptococcus: cell death and inflammation|
JA Tsatsaronis, MJ Walker, ML Sanderson-Smith
PLoS pathogens 10 (8), e1004266, 2014
|A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides|
A Hollands, D Gonzalez, E Leire, C Donald, RL Gallo, ...
Journal of Biological Chemistry 287 (49), 40891-40897, 2012
|Parameters governing invasive disease propensity of non-M1 serotype group A streptococci|
PG Maamary, ML Sanderson-Smith, RK Aziz, A Hollands, JN Cole, ...
Journal of innate immunity 2 (6), 596-606, 2010
|Immune Cross-Opsonization Withinemm Clusters Following Group AStreptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity|
HR Frost, D Laho, ML Sanderson-Smith, P Licciardi, S Donath, N Curtis, ...
Clinical infectious diseases 65 (9), 1523-1531, 2017
|Plasmin (ogen) acquisition by group A Streptococcus protects against C3b-mediated neutrophil killing|
D Ly, JM Taylor, JA Tsatsaronis, MM Monteleone, AS Skora, CA Donald, ...
Journal of innate immunity 6 (2), 240-250, 2014
|Group A streptococcal M-like proteins: from pathogenesis to vaccine potential|
HR Frost, M Sanderson-Smith, M Walker, A Botteaux, PR Smeesters
FEMS microbiology reviews 42 (2), 193-204, 2018
|The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon‐γ in a humanized mouse model of graft‐versus‐host disease|
NJ Geraghty, L Belfiore, D Ly, SR Adhikary, SJ Fuller, W Varikatt, ...
Clinical & Experimental Immunology 190 (1), 79-95, 2017